J. Bradley Nelson, PharmD, CSMC's Posts
Cancer Drug Pipeline 2021: How to Improve Affordability for Plans & Members
In a year of COVID-19 and the race to an effective vaccine, news about several breakthrough treatments for cancer got...
Why the 2021 Drug Pipeline Will Make You Rethink Your Pharmacy Benefits Strategies
Top Three Things You'll Learn Potential blockbuster specialty drugs in the pipeline for 2021-2022 How the new drugs coming to...
Analyzing the Value of Retail-30 vs Retail-90 Benefit Design Strategies
Dispensing a 90-day supply of medications has become a common benefit design in prescription drug programs today. Proponents tout lower costs...
How the Pharmacy Benefits Industry Has Changed Over the Last Two Decades
What You'll Learn Changes in the drug product mix and the impact on pharmacy benefits plan sponsors How specialty...
What it Means to Optimize the Drug Formulary
This is part three of a series on drug formularies. Check out part 1 and part 2. Drug formularies are...
DAW Penalties: Promoting Lower-Cost Generics Over Brand-Name Drugs
A generic-first strategy has proven to be a successful strategy used by self-funded employers to manage high prescription drug costs....
Is it Time to Refresh Member Cost Share or Stay the Course?
At RxBenefits, we’ve been asked a lot about benefit plan design – copays, tiering, plan exclusions, and more. When...
Why Employers Need Stop Loss Coverage & How to Prevent Unnecessary Lasers
Stop-loss protection is designed to provide self-insured employers with risk coverage for catastrophic claims. When put in place for a...
Utilizing A Data-Driven Approach for Pharmacy Benefits Decision-Making
Video Transcript Pharmacy benefits data represents your unique footprint. Think of it as a fingerprint. It is a unique signature...
What Drug Manufacturers Don’t Want You to Know About Low Clinical Value Medications
Prescription drug manufacturers are making great strides in developing medications designed to treat both common and complex diseases. The latest...